MM2026

Limitless

← FULL PROGRAM
S7

Beyond tetanus: Maximising vaccine value in emergency wound management

Date & Time: Friday 23 October · 1215-1315
Industry funded

This session is generously funded by Sanofi.

Hospital pharmacists play a critical role in vaccine stewardship, particularly in emergency settings where tetanus prophylaxis is routine. This session examines how Australia's recent diphtheria and pertussis outbreaks reveal an untapped opportunity: every tetanus shot for wound management already provides diphtheria protection through dT, but a simple formulary substitution to dTpa could add pertussis coverage without any workflow changes. Drawing on Queensland outbreak data and implementation research, this presentation provides hospital pharmacists with evidence-based rationale and practical strategies to optimise vaccine value in emergency departments.

This session is supported by industry funding. The presenting speaker is independent and is not employed by, or representing, the supporting company.

Speakers

Dr
Michael
Nissen
Director of Research, The Prince Charles Hospital, Metro North Health, Brisbane, Qld; Adjunct Associate Professor, Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, University of Queensland, Brisbane, Qld
crossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram